#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

Psoriáza_ruce

Brodalumab –⁠ 5 Years of Data on Efficacy, Safety, and Quality of Life Improvement in Plaque Psoriasis

20. 4. 2020 Source: Topical Treatment of Psoriasis

Chronic inflammatory diseases, including psoriasis, require therapeutic approaches that maintain efficacy and tolerability even during long-term treatment. One such modern modality is brodalumab, a fully human monoclonal antibody against the A subunit of the interleukin (IL) 17 receptor. A study published last year evaluated its long-term efficacy and safety in patients with moderate to severe plaque psoriasis and also focused on improving their quality of life.

ledviny záda bolest muž medicína

Impact of Candesartan on Achieving Remission in Patients with Active IgA Nephropathy

IgA nephropathy is the most common glomerulonephritis worldwide and in the Czech Republic. The…
18. 4. 2020 Source: Sartans in the Treatment of Hypertension
zdravý životní styl sport jídlo pohyb cvičení medicína

Impact of Lifestyle on the Benefit of Pharmacotherapy for Hypertension and Dyslipidemia

Antihypertensive and hypolipidemic therapy reduces the risk of cardiovascular (CV) diseases.…
18. 4. 2020 Source: Sartans in the Treatment of Hypertension

Incontinence as a Consequence of Surgical Procedure on the Prostate

Despite the advent of new surgical methods, urinary incontinence after prostate procedures remains…
17. 4. 2020 Source: Incontinence
Analýza dat

6 Years Follow-Up of Patients with Breast Cancer in the APHINITY Study

The primary analysis of results from the APHINITY clinical trial supported the combined anti-HER2…
17. 4. 2020 Source: Breast Carcinoma

Idiopathic Pulmonary Fibrosis from the Perspective of an Outpatient Pulmonologist

Idiopathic pulmonary fibrosis represents a rare disease of lung tissue with an as-yet-unexplained…
16. 4. 2020 Source: Pulmonary Fibrosis
z UL

Thinking About Idiopathic Pulmonary Fibrosis?

Idiopathic pulmonary fibrosis (IPF) is one of the most prognostically severe and difficult-to-treat…
16. 4. 2020 Source: Pulmonary Fibrosis
Muž se chytá za srdce

American Heart Association: Side Effects of Statins Overview and Context

The American Heart Association (AHA) report provides an updated summary of knowledge on the safety…
15. 4. 2020 Source: Cardiovascular Risks
histologie_genetika_onkologie

Third Generation Targeted Therapy for ROS1-Positive NSCLC

The potent third-generation tyrosine kinase inhibitor, lorlatinib, has shown activity in…
15. 4. 2020 Source: Genetic Profile and Treatment of NSCLC
rentgen_plic_snimek

Key Role of HRCT in Diagnosing Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis is often an unjustly overlooked disease. The truth is that it is a…
15. 4. 2020 Source: Pulmonary Fibrosis
1 154 155 156 157 158 169
Filter by speciality
Remove filters

Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#